Sen­ate com­mit­tee ad­vances PBM bill as bi­par­ti­san re­forms gain trac­tion

Phar­ma­cy ben­e­fit man­agers are be­gin­ning to see en­e­mies on both sides of the aisle: On Wednes­day, a US Sen­ate com­mit­tee ad­vanced to the full cham­ber a bill to in­crease PBM trans­paren­cy and crack down on what law­mak­ers and crit­ics say are de­cep­tive prac­tices.

The Sen­ate Com­mit­tee on Com­merce, Sci­ence and Trans­porta­tion ad­vanced the bill by a bi­par­ti­san 18-9 vote, af­ter hear­ing tes­ti­mo­ny last Feb­ru­ary doc­u­ment­ing how PBMs con­trol sev­er­al key ar­eas of the drug dis­tri­b­u­tion and pay­ment sys­tem. The Phar­ma­cy Ben­e­fit Man­ag­er Trans­paren­cy Act, in­tro­duced by com­mit­tee chair Maria Cantwell (D-WA) and Bud­get Com­mit­tee rank­ing mem­ber Chuck Grass­ley (R-IA), would make it un­law­ful for PBMs to en­gage in:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER